2 news items
Bruker Inks Share Purchase Agreement To Acquire Molecular Diagnostics Company ELITechGroup; Deal Value €870 M Cash, Excluding Carved Out ELITech Clinical Chemistry Business
BRKR
28 Feb 24
As reported in an 8-K SEC filing on December 26, 2023, Bruker had previously entered into a put option agreement with the sellers, pending workers
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
BRKR
28 Feb 24
into a put option agreement with the sellers, pending workers' council consultations in France and The Netherlands. This put option has now been exercised
- Prev
- 1
- Next